#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant glioma Malignant neoplasm of choroid Stiff person syndrome Gaucher's disease type I Congenital myopathy Acute myeloid leukaemia recurrent Albright's disease Central nervous system neoplasm Congenital ectodermal dysplasia Lymphangioma Acute graft versus host disease Astrocytoma malignant Epstein-Barr virus infection Paroxysmal nocturnal haemoglobinuria Alveolar proteinosis More trials…

    Learn about Rare Diseases

    Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Krabbe’s disease – Treatment Fragile X syndrome – Basic Information Metachromatic leukodystrophy – Trials in Disease Soft tissue sarcoma Netherton’s syndrome – Diagnostics KBG syndrome – Trials in Disease Activated PI3 kinase delta syndrome – Diagnostics Glomerulonephritis membranoproliferative – Treatment Osteosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nicotine Resinate Nystatin Lna043 Lutetium (177Lu) Oxodotreotide Zinc Oxide Db-Oto-5 Fosaprepitant Etoposide Phosphate Abelacimab Relebactam Nicotinamide Bp Futibatinib Senicapoc Citric Acid POLYSORBATE 80 Quinapril Hydrochloride ORX750 Donepezil Hydrochloride GVV858 Olanzapine More therapies…

    Learn about Your Condition

    Ataxia telangiectasia Aneurysm ruptured Autism spectrum disorder Glioblastoma Hyperglycaemia Delayed graft function Peyronie's disease Small cell lung cancer Hypervolaemia Renal cancer Hypoalbuminaemia Fibromyalgia Breast cancer metastatic Infantile spasms Cervix carcinoma stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Comparing Anakinra versus Immunoglobulin for Treatment-Resistant Kawasaki Disease in Patients Who Failed Initial Immunoglobulin Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Kawasaki’s disease
    Investigated Drugs:
    • Anakinra
    • Human Normal Immunoglobulin
    France

  • Study on the Effectiveness of Oxaliplatin or Gemcitabine Chemotherapy in Patients with Resected Pancreatic Cancer Using Standard or Genetic Allocation Methods

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    Germany Sweden

  • Study of Pembrolizumab, Dendritic Cell Vaccine, Trifluridine/Tipiracil, and Bevacizumab for Patients with Metastatic Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Autologous Tumor Lysate-Loaded Dendritic Cells
    • Tipiracil Hydrochloride
    • Trifluridine
    Italy

  • Study of Amoxicillin-clavulanic acid, Piperacillin-tazobactam and Meropenem dosing in critically ill children with systemic infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Amoxicillin Sodium
    • Clavulanic Acid
    • Linezolid
    Belgium

  • Study on Ifosfamide and Doxorubicin for Patients with High-Grade Soft Tissue Sarcoma in the Limbs and Trunk Wall

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Doxorubicin Hydrochloride
    • Ifosfamide
    Norway

  • Study on Botulinum Toxin Type A and Sodium Chloride for Patients with Treatment-Resistant Chronic Cluster Headache

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cluster headache
    Investigated Drugs:
    • Botulinum Toxin Type A
    • Sodium Chloride
    Germany Norway
Previous Page
1 … 408 409 410 411 412 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!